drugset / Trial / NCT02495272

Postpartum Uterotonic Administration

NCT02495272 ↗

RandomizedParallel-groupSingle-blindPrevention

Summary

The investigators are planning to determine the effect of the timing of oxytocin administration on the amount of blood loss, necessity for additional medical or surgical interventions.

Timeline

Start
2014-06
Primary completion
2015-12
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 10 iu Intramuscular

Indications

No indication recorded.